IDEXX Laboratories Inc. (Nasdaq: IDEXX) on Tuesday posted second-quarter earnings and revenue that beat expectations and raised its full-year financial outlook.
The Westbrook-based veterinary diagnostics company reported diluted earnings per share of $2.67, an increase of 71% as reported and 77% on a comparable basis. Earnings per share exceeded the $2.43 per share consensus estimate of analysts polled by Zacks Investment Research. Read more
